Anavex Life Sciences Corp (AVXL)

[imho]

It's not a catalyst; the drug is safe and we want to do a phase 3. The FDA guidance will be on how big a trial, qualification criteria, endpoints, etc. They will be sensible.

It would be a catalyst for the stock price, if the data presented is extremely positive and the FDA designates the P3 as breakthrough or fast tracked. I am not speculating that, but it is a possibility and it would definitely be a catalyst for tor the stock.

t will be interesting to see if we actually do it in PDD and/or PD. I would imagine endpoints for both.

Yes very interesting.

IMHO